Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02792764 · ClinicalTrials.gov registry record
Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs
A clinical trial, sponsored by C. R. Bard.
- Completed
- Registry status
- 300
- Enrollment target
NCT02792764: Completed study, sponsored by C. R. Bard.
NCT02792764 is a clinical trial that has completed, run by C. R. Bard. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02792764 has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.
Primary Outcome
Subjects medical records will be retrospectively reviewed from present day back to January 1, 2008 to assess for complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-03 |
What the finished NCT02792764 record still lists
NCT02792764 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02792764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02792764 about?
NCT02792764 is a clinical study titled "Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs". This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.
What is the current status of trial NCT02792764?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2014-02. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02792764?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia